cbdMD (YCBD) Enterprise Value (2016 - 2026)
cbdMD (YCBD) posted Enterprise Value of -$3.4 million for Q4 2025, down 49.83% sequentially from -$2.3 million in Q3 2025, and down 71.96% YoY from -$12.1 million in Q4 2024.
cbdMD (YCBD) Enterprise Value (2016 - 2026) Analysis & Trends
cbdMD has reported Enterprise Value for 10 years, with the latest figure at -$3.4 million in Q4 2025.
- Quarterly Enterprise Value fell 71.96% year-over-year to -$3.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3.4 million (down 71.96% YoY) and the FY2025 annual result came in at -$2.3 million, up 7.8% from the prior year.
- Enterprise Value retreated to -$3.4 million in Q4 2025 per YCBD's latest filing, from -$2.3 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$1.1 million in Q2 2025 and troughed at -$26.4 million in Q3 2021.
- A 5-year average of -$7.5 million and a median of -$2.6 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2021 and 2023: Enterprise Value sank 78.07% in 2021, then soared 88.01% in 2023.
- Over 5 years, Enterprise Value stood at -$19.7 million in 2021, then surged by 77.9% to -$4.4 million in 2022, then jumped by 65.43% to -$1.5 million in 2023, then sank by 30.92% to -$2.0 million in 2024, then plunged by 71.96% to -$3.4 million in 2025.
- According to Business Quant data, Enterprise Value over the past three periods registered -$3.4 million, -$2.3 million, and -$1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | -164.00 Mn |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | -2.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.12 Mn |
| Dec 31, 2025 | -3.39 Mn |
| Sep 30, 2025 | -2.26 Mn |
| Jun 30, 2025 | -1.06 Mn |
| Mar 31, 2025 | -1.77 Mn |
| Dec 31, 2024 | -1.97 Mn |
| Sep 30, 2024 | -2.45 Mn |
| Jun 30, 2024 | -2.40 Mn |
| Mar 31, 2024 | -2.11 Mn |
| Dec 31, 2023 | -1.50 Mn |
| Sep 30, 2023 | -1.80 Mn |
| Jun 30, 2023 | -2.85 Mn |
| Mar 31, 2023 | -1.72 Mn |
| Dec 31, 2022 | -4.35 Mn |
| Sep 30, 2022 | -7.72 Mn |
| Jun 30, 2022 | -9.55 Mn |
| Mar 31, 2022 | -14.34 Mn |
| Dec 31, 2021 | -19.70 Mn |
| Sep 30, 2021 | -26.44 Mn |
| Jun 30, 2021 | -19.00 Mn |